UV Exposure & Risk of Cutaneous Melanoma in Skin of Color

By Rachel Fischer, Ph.D., Senior Associate, Scientific Program and Grants Administration | 14 April 2021 In News, Prevention, Science

In JAMA Dermatology, a team led by Adewole S. Adamson, MD, from The University of Texas at Austin, investigates whether there is an association, specifically in People of Color, between UV exposure and melanoma. MRA breaks down what this research means and how it should impact your sun safety practices.

Read More


Mitch Diamond Honors His Grandfather’s Legacy By Raising Awareness of Melanoma

By Cody R. Barnett, MRA Director of Communications | 13 April 2021 In Melanoma Stories

Five years ago, when he was just 8-years old, Mitch Diamond lost his grandfather due to melanoma. Now, for his Bar Mitzvah, he’s asking his friends, family, and community to help him raise awareness of and help prevent melanoma.

Read More


A Melanoma Miracle Paid Forward

By Tyler Brown, MRA Senior Associate, Patient Engagement & Operations | 26 March 2021

When Lauren was living in Tanzania, she made a bucket list that included 'seeing a miracle." Little did she know she would become her own melanoma miracle. Almost eight years later, she is just beginning her career as a nurse and continues to be NED.

Read More


Dr. James Allison on the Path to More Effective Immunotherapies

24 March 2021 In Science, Treatment

When MRA co-founder and Board Chair Debra Black introduced James Allison of the University of Texas MD Anderson Cancer Center at MRA’s 2020 Scientific Retreat, she described him as the man “who changed the way cancer patients are treated forever.” This fitting introduction is due to Allison’s pioneering work to mainstream the...

Read More


Craig Finds Meaning in His Melanoma Diagnosis in the COVID-19 Era

By Cody R. Barnett, MRA Director of Communications | 11 March 2021 In Melanoma Stories

“I believe there is a reason that I’m going through this. If I can help prevent someone else’s melanoma, or make their journey easier, or help advance research – that’d be worth it,” says Craig. “I feel honored to be part of the melanoma community. It’s a powerful community – and I feel obligated to do something in support of it.”

Read More


Relentless in the Fight: Dr. F. Stephen Hodi

5 March 2021 In Melanoma Stories, Science

Every revolution needs trailblazers—people who restlessly and relentlessly search for paths forward. At MRA, we’re fortunate to partner with innovative trailblazers who are guiding the entire field of melanoma further, such as two time MRA-funded investigator Dr. F. Stephen Hodi.

Read More


Denise Kellen is On a Mission to Advance Melanoma Prevention & Early Detection

By Cody R. Barnett, MRA Director of Communications | 23 February 2021 In Melanoma Stories

Growing up – from June until August – Denise Kellen and her family practically lived at Lido Beach on Long Island’s south shore. They’d swim, play on the surf, read, and sunbathe. Like clockwork she’d develop two to three severe sunburns that would leave her pale skin a fiery red before peeling away. If only Denise knew then what she knows now.

Read More


Join MRA for Exciting Two-Day Virtual Event - April 15 and May 6!

22 February 2021 In Events

Throughout the event, you’ll hear from leading experts in the melanoma field and have the opportunity to ask questions, discuss, and network with other people who are going through their own melanoma journey. Each session will provide information, insight, and strategies to help navigate melanoma diagnosis, treatment, or beyond.

Read More


Estimating Melanoma Risk by Examining Skin’s Mutational Burden

By Cody R. Barnett, MRA Director of Communications | 10 February 2021 In Prevention, Science

 We’ve known for decades that most melanomas – formed from the color-producing cells in our skin called melanocytes – are predominantly caused by UV-radiation-induced damage from the sun or indoor tanning devices. This damage is cumulative but is often invisible.

Read More


Melanoma Models for the Next Decade of Progress

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 8 February 2021 In Science

Despite the tremendous progress that’s been made over the past decade for patients with melanoma, nearly half of patients do not benefit from currently approved therapies. Developing novel therapies for these individuals is a daunting challenge that begins with laboratory studies and hopefully ends with a drug candidate that is...

Read More


Login

×